Market Overview:
The global lice treatment market size is expected to reach USD 1,684.72 million by 2032,exhibiting the CAGR of 5.9% during the forecast period.
Market Definition:
Lice, which are wingless insects that feed on human blood, reside on the heads or scalps of their hosts. When lice feed on humans’ blood, they release saliva into the skin. The injection of saliva prevents blood from clotting. Pruritus is an illness resulting from lice saliva infiltrating the human bloodstream. Some individuals may experience strong allergic reactions due to the saliva of lice, while the sharp claws of the lice can induce discomfort and itching as they travel through strands of hair. Pediculicides, also known as lice treatments, can be obtained without a prescription or over-the-counter. Shampoos, lotions, and cream rinses are included in the group.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/lice-treatment-market/request-for-sample
Growth Drivers and Opportunities:
- Significant lifestyle alterations, including shifts in living conditions and hygiene habits, are causing an increase in lice infestations and driving up the need for successful treatment choices. Reasons such as increased travel and fast urbanization, particularly in developing countries, are also predicted to lead to more cases of lice, leading to an increase in market growth.
- Global market growth is expected to be boosted by the rising number of product approvals from top regulatory authorities and agencies for treating lice infestations and related problems.
Key Players:
Because there are so many companies in the market, it is expected to be both competitive and fragmented. Here is the list of the leading companies operating in the lice treatment market:
- Arbor Pharmaceuticals LLC (US)
- Bayer AG (Germany)
- Insight Pharmaceuticals (US)
- Omega Pharma NV (Belgium)
- Parasol Laboratories (US)
- Pfizer Inc. (US)
- Prestige Brands Holding Inc. (US)
- Sanofi SA (France)
- Sumitomo Chemical Co. Ltd. (Japan)
- TAA Industries (Australia)
- TecLabs Inc. (US)
- Tyratech Inc. (US)
Segmentation Overview:
Lice Treatment Market, Type Outlook (Revenue – USD Million, 2019-2032)
- Pediculosis Capitis
- Pediculosis Corporis
- Pediculosis Pubis
Lice Treatment Market, Treatment Outlook (Revenue – USD Million, 2019-2032)
- OTC Products
- Prescription Medications
- Others
Lice Treatment Market, Distribution Channel Outlook (Revenue – USD Million, 2019-2032)
- Hospitals and Clinics
- Retail Pharmacies
- Online Platform
- Others
The lice treatment market is mainly segmented based on treatment, type, region, and distribution channel. Based on the type analysis, in 2023, the pediculosis capitis segment held the largest market share. Progress in formulation technology is continuously resulting in the development of innovative treatment options like lotions, shampoos, and combing devices, which will greatly boost the growth of this segment.
Moreover, according to the treatment analysis, in 2023, the OTC products segment held the majority revenue share driven by factors such as more people spending time in close contact settings and notable lifestyle changes.
Recent Developments in the Veterinary Medicine Industry:
- First Oral Lice Treatment for Sheep (May 2023):
The Australian Pesticides and Veterinary Medicines Authority (APVMA) announced the registration of the first oral lice treatment for sheep in the world. This innovative product contains fluralaner, a novel active ingredient designed to control lice in both sheep and lambs. It is particularly significant as it addresses strains resistant to synthetic pyrethroids and various insect growth regulators, offering an effective solution for lice management in livestock.
The substantial increase in the prevalence of lice parasites contamination worldwide and growing research & development activities or efforts leading to significant advancements in product formulations including improved efficacy, developing user-friendly application methods, and incorporating new active ingredients, are key factors driving the market growth. Additionally, rising proliferation for awareness campaigns and education programs by healthcare organizations and authorities to raise awareness about lice infestations and available treatment options, are further likely to have positive impact on market growth.